REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Kolosal Pratama (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pt Kolosal Pratama Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Kolosal Pratama is based in Indonesia, with the head office in East Jakarta. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. Pt Kolosal Pratama was incorporated on February 14, 2002. From the latest financial highlights, Pt Kolosal Pratama reported a net sales revenue increase of 12.13% in 2024. Its’ total assets recorded a growth of 12.68%.

Headquarters
RT 001 RW 008, Ruko Graha Mas Pemuda Blok AC No 15-16
East Jakarta; Jakarta; Postal Code: 13220

Contact Details: Purchase the Pt Kolosal Pratama report to view the information.

Website: http://www.kolosalpratama.com

Basic Information
Registered Capital:
Purchase the Pt Kolosal Pratama report to view the information.
Financial Auditors:
Purchase the Pt Kolosal Pratama report to view the information.
Incorporation Date:
February 14, 2002
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Commissioner
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pt Kolosal Pratama report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
12.13%
Total Operating Revenue
12.13%
Total Assets
12.68%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?